Our previous studies have shown that analgesia induced by electroacupuncture (EA ) of different frequencies is mediated by different kinds of Opioid peptides. Th us, low frequency (2 Hz) EA increases the release of en...Our previous studies have shown that analgesia induced by electroacupuncture (EA ) of different frequencies is mediated by different kinds of Opioid peptides. Th us, low frequency (2 Hz) EA increases the release of enkepahlins (ENK) and beta endorphin (END) in the central nervous system, whereas high frequency EA (100 Hz) increases the release of dynorphin (DYN) in the spinal cord. In recent years , ne w experiments have yielded new data that further substantiate the hypothesis put forward several years ago. 1. How to accelerate the release of endomorphin (EM) in the central nervous syst em EM is an endogenously produced morphine like peptide composed of 4 amino aci ds, showing a high specificity to mu Opioid receptor. Han et al (1999) have show n that intrathecal injection of anti EM antibody to the rat spinal cord blocked 2 Hz but not 100 Hz EA induced analgesia. Likewise, intracerebroventricular (IC V) injection of anti EM antibody or the mu receptor blocker CTOP attenuated 2 H z but not 100 Hz EA induced analgesia (Huang et al, 2000). The results suggest tha t 2 Hz EA accelerated the release of EM in brain and spinal cord to interact wit h mu Opioid receptor to produce analgesic effect. High frequency EA was not effec tive. 2. How to activate both neural pathways mediating both low and high frequency EA effect Pharmacological studies have shown that intrathecal injection of both enkepah lin and dynorphin produces a synergistic analgesic effect. It would naturally l ead to the supposition that EA analgesia may be potentiated if one could activat e both pathways simultaneously. Two paradigms could be used. Paradigm A is to us e low frequency (LF) and high frequency (HF) alternatively, each lasting for a c ertain period (already optimized to be 3 sec). Paradigm B is to use LF in one li mb and HF in another limb. Pharmacological studies were used to analyze the recept or mechanisms; neurochemical detection and antibody microinjection technique wer e used to identify the neuropeptides responsible for producing the展开更多
"针刺临床试验干预措施报告标准"(Standards,for Reporting Interventions in Clinical Trials of Acupuncture,STRICTA)于2001年和2002年在5种期刊上发表。该指南以对照试验检查清单及解释的形式供作者和期刊编辑使用,旨在..."针刺临床试验干预措施报告标准"(Standards,for Reporting Interventions in Clinical Trials of Acupuncture,STRICTA)于2001年和2002年在5种期刊上发表。该指南以对照试验检查清单及解释的形式供作者和期刊编辑使用,旨在提高针刺临床试验报告的质量,尤其是对其中干预措施的报告,因而有助于对这些试验的解释和重复。随后对STRICTA的应用及影响的述评都强调了STRICTA的价值,也提出了改进和修订的建议。为使修订过程顺利进地,STRICTA工作组、CONSORT工作组和中国Cochrane中心于2008年开始合作,召集成立的包含47名成员的专家小组对清单的修改稿提出了电子版反馈意见。在后来于弗莱堡(Freiburg)召开的见面会上,由21名专家组成的工作组进一步修订了STRICTA对照检查清单,并计划如何对其进行发布。新的STRICTA对照检查清单作为CONSORT的正式扩展版,包含6项条目及17条二级条目。这些条目为报告针刺治疗的合理性、针刺的细节、治疗方案、其他干预措施、治疗师的背景以及对照或对照干预提供了指南。而且,作为修订工作的一部分,对每一条目作了详尽解释,并针对每一条目给出了良好报告的实例。此外,STRICTA中的"对照"(controlled)一词被替换成了"临床"(clinical),以示STRICTA适用于更广泛的各类临床评价设计,包括非对照结局研究和病例报道。修订的STRICTA对照检查清单有望与CONSORT声明及其非药物治疗扩展版一起共同提高针刺临床试验的报告质量。展开更多
文摘Our previous studies have shown that analgesia induced by electroacupuncture (EA ) of different frequencies is mediated by different kinds of Opioid peptides. Th us, low frequency (2 Hz) EA increases the release of enkepahlins (ENK) and beta endorphin (END) in the central nervous system, whereas high frequency EA (100 Hz) increases the release of dynorphin (DYN) in the spinal cord. In recent years , ne w experiments have yielded new data that further substantiate the hypothesis put forward several years ago. 1. How to accelerate the release of endomorphin (EM) in the central nervous syst em EM is an endogenously produced morphine like peptide composed of 4 amino aci ds, showing a high specificity to mu Opioid receptor. Han et al (1999) have show n that intrathecal injection of anti EM antibody to the rat spinal cord blocked 2 Hz but not 100 Hz EA induced analgesia. Likewise, intracerebroventricular (IC V) injection of anti EM antibody or the mu receptor blocker CTOP attenuated 2 H z but not 100 Hz EA induced analgesia (Huang et al, 2000). The results suggest tha t 2 Hz EA accelerated the release of EM in brain and spinal cord to interact wit h mu Opioid receptor to produce analgesic effect. High frequency EA was not effec tive. 2. How to activate both neural pathways mediating both low and high frequency EA effect Pharmacological studies have shown that intrathecal injection of both enkepah lin and dynorphin produces a synergistic analgesic effect. It would naturally l ead to the supposition that EA analgesia may be potentiated if one could activat e both pathways simultaneously. Two paradigms could be used. Paradigm A is to us e low frequency (LF) and high frequency (HF) alternatively, each lasting for a c ertain period (already optimized to be 3 sec). Paradigm B is to use LF in one li mb and HF in another limb. Pharmacological studies were used to analyze the recept or mechanisms; neurochemical detection and antibody microinjection technique wer e used to identify the neuropeptides responsible for producing the
文摘"针刺临床试验干预措施报告标准"(Standards,for Reporting Interventions in Clinical Trials of Acupuncture,STRICTA)于2001年和2002年在5种期刊上发表。该指南以对照试验检查清单及解释的形式供作者和期刊编辑使用,旨在提高针刺临床试验报告的质量,尤其是对其中干预措施的报告,因而有助于对这些试验的解释和重复。随后对STRICTA的应用及影响的述评都强调了STRICTA的价值,也提出了改进和修订的建议。为使修订过程顺利进地,STRICTA工作组、CONSORT工作组和中国Cochrane中心于2008年开始合作,召集成立的包含47名成员的专家小组对清单的修改稿提出了电子版反馈意见。在后来于弗莱堡(Freiburg)召开的见面会上,由21名专家组成的工作组进一步修订了STRICTA对照检查清单,并计划如何对其进行发布。新的STRICTA对照检查清单作为CONSORT的正式扩展版,包含6项条目及17条二级条目。这些条目为报告针刺治疗的合理性、针刺的细节、治疗方案、其他干预措施、治疗师的背景以及对照或对照干预提供了指南。而且,作为修订工作的一部分,对每一条目作了详尽解释,并针对每一条目给出了良好报告的实例。此外,STRICTA中的"对照"(controlled)一词被替换成了"临床"(clinical),以示STRICTA适用于更广泛的各类临床评价设计,包括非对照结局研究和病例报道。修订的STRICTA对照检查清单有望与CONSORT声明及其非药物治疗扩展版一起共同提高针刺临床试验的报告质量。
